Search Conferences and Exhibitions

Advances in Chronic Pain Management brings together leading experts in the fi  elds of pain, anaesthesia and neurology to discuss the central issues and current challenges involved in the management of patients with
chronic pain.

It is anticipated that participants will benefit from:

An understanding of the neurological basis of pain and how pain can be imaged in the brain Analysis of the psychosocial aspects of chronic pain and cognitive behavioural treatments
Insights into the optimal approaches for managing patients with fi  bromyalgia, neuropathic pain, trigeminal neuralgia, cancer-related pain and chronic pain following spinal cord injury
Updates on the advances in treatment for chronic pain including pharmacotherapies, radiofrequency
interventions, TENS and neuromodulatory techniques
Panel discussion about the impact of the NICE guidelines for lower back pain interventions
An opportunity to share and exchange ideas with leading practitioners in the fileld

On behalf of the UC San Diego School of Medicine, Department of Medicine, it is our privilege to invite you to participate in the Topics and Advances in Internal Medicine and Pulmonary and Critical Care Medicine postgraduate courses.

These courses have a history of being presented to a large audience every year and in the past decade we have consistently had over 400 attendees. Since many attendees participate every year, the program always consists of all new material.

Topics and Advances in Internal Medicine is divided into two three-day sessions and you may enroll in one session or both. Optional workshops are presented on Sunday to allow participants the opportunity to explore a topic in detail. Or, you can choose to take the day off and enjoy San Diego.

This program will feature presentations of the latest information in virtually every area of medicine. The program is divided into sessions that focus on Health Maintenance/Lifestyle Issues, General Internal Medicine, Dermatology, Rheumatology, Women’s Health, Hospitalist Program, Neurology, Electronic Records, Humanities in Medicine, Dermatology, Cardiology, Infectious Diseases, Oncology, Hematology, Geriatrics, Palliative Medicine, and Psychiatry.

Session A: March 4–6, 2010

• Health Maintenance/Lifestyle Issues
• General Internal Medicine
• Dermatology
• Rheumatology
• Women’s Health
• Hospitalist Program
• Neurology
• Electronic Records

Session B: March 8–10, 2010

• Humanities in Medicine
• Dermatology
• Cardiology
• Infectious Diseases
• Oncology
• Hematology
• Geriatrics
• Palliative Medicine
• Psychiatry

Optional Workshops: March 7, 2010

• Pain Management
• Diagnostic and Therapeutic Musculoskeletal Injection
• Classic Case Studies in Cardiology
• Electronic Recordkeeping

Will be followed by Pulmonary and Critical Care Medicine: March 11–12, 2010

• Describe the applications of modern MRI imaging to solving clinical questions in the work-up of patients with many central nervous system, musculoskeletal, spine and abdominal-pelvic diseases
• Assess both the advantages and limitations of these techniques
• Be aware of alternative imaging choices
• Develop differential diagnoses based on magnetic resonance imaging and disease
• Demonstrate how to apply modern imaging to the performance of spine interventional procedures in radiology practice to alleviate spinal pain, treatment of osteoporotic and malignant fractures, biopsy, spinal lesions and treat vascular abnormalities of the spine

The Second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic will return to Jordan on March 7-10, 2010, under the Patronage of His Majesty King Abdullah II ibn Al Hussein. This innovative conference will provide an overview of the most cutting-edge cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction, and novel therapeutic development. In-depth Workshop Sessions will discuss the nuances and applications of various new technologies, while Educational Sessions will delve into grant writing and funding sources, clinical trial design, and scientific writing and the publication process. 

In order to make any advances in translational cancer medicine, there must be open lines of communication between researchers and clinicians. Therefore, this conference will appeal to a broad spectrum of cancer researchers and we encourage early-career scientists, especially, to attend. Oral presentations from proffered abstracts will be featured in several sessions and poster sessions will be held to allow investigators to present and discuss their latest research in an informal setting. In addition, social events and career development sessions are being planned to encourage interaction among attendees themselves and with the conference speakers.

Through this important international conference, we hope that there will be an interdisciplinary exchange of information as well as the blossoming of new collaborations which are both essential for progress against cancer to be made. We hope you will join us at the Dead Sea in Jordan for this exciting program.

As surgery and percutaneous coronary interventions move closer and closer together, the interventionalist of the future will treat the entire arterial tree - coronary, peripheral and cerebral.  New techniques and approaches, now being developed in Europe, South America and the Far East, as well as in major American centers, will soon be part of mainstream practice in America.  This worldwide cooperation shows that, as in other areas, interventional cardiology has become a global discipline.

The scientific program for the special 25th Anniversary celebration is currently being formulated to include an exceptional historical retrospective, as well as presentations on new, leading-edge techniques and technologies for coronary and endovascular intervention.  Check back often for updates on the detailed agenda, which will be posted right here.

• To provide the most recent updates on applications of MDCT, and MR for evaluation of diseases involving the thorax, GI, GU, Vascular and MSK
• To illustrate advanced and emerging applications in patient safety related to radiation dose and contrast media
• To provide updates on the use of MDCT and MR for diseases of the heart and vascular system
• To provide most recent data state-of-the-art MDCT for colon cancer screening
• To provide insight into new/evolving topical areas in Body CT/MR as well as into relevant political developments

The goals of the 1st NWAC World Anesthesia Congress are:

• Delivery of a one-of-a-kind, uncompromising Global Didactic Curriculum
• Advancement of Research and Academia in the field of Anesthesiology at large
• Foster networking and international/inter-institutional relationship building
• Relationship building among academicians, practitioners and industry in quest for better and safer patient care.

In meeting these goals, the NWAC Dubai 2010 will showcase cutting edge presentations by some of the most sought after experts in the field. NWAC 2010 will also highlight the most recent developments in clinical and practical aspects in Anesthesiology. Multitude of workshop sessions, panels and problem-based luncheons will provide both intensive learning through the direct interaction with the faculty and hands-on experience. While NYSORA’s focus has traditionally been on regional anesthesia, acute pain management and ambulatory surgery, NWAC program focuses on the review of the modern trends and practices of Anesthesiology at large.

7-Night Caribbean Cruise from Tampa, FL

Program Purpose and Objectives

To discuss the structure of the major public policy programs in US health care, the challenges and opportunities of the health care reform agenda and the "basics" of health care advocacy. The course is intended as a general overview of major public health care programs and policy similar to what a congressional health staff person may receive. Reference lists and objective sources of policy information will be used throughout. The participants will emerge with a deeper understanding of health policy, opportunities for health care reform, the jurisdiction of relevant congressional and administrative offices, a basic "how-to" of health care advocacy and an extensive bibliography of objective sources of policy research.

Preliminary topics for discussion

1. Overview of Public Health Care Programs: Medicare, Medicaid, SCHIP and VA systems
2. Medicare Payment Policies: Outpatient, Hospital, Skilled Nursing Facilities
3. Medicaid and SCHIP: growing numbers and implication for practice in trying economic times
4. Health Care Reform Efforts: Medical Home, Health Information Technology, Universal Converge, Comparative Effectiveness, Quality measurement and reporting
5. Advocacy 101: engaging in the process

• Attend presentations by more than 350 speakers
• Hear representatives from the EMEA, FDA and regulatory agencies throughout Europe
• Attend preconference tutorials
• Network with professional colleagues from around the world
• Visit more than 200 exhibitors in Europe’s largest interactive exhibit hall

Conference Topics:

• Planning for HPB Surgery and Transplantation
• Techniques for HPB Surgery and Transplantation
• Immunosuppression
• Outcome
• Dealing with post-op Complications
• Extreme Surgery
• Unresectable Disease
• Hepatocellular Carcinoma
• Case Presentations - (Portal HTN/ Splanchnic venous thrombosis)
• Surgical Videos - (Minimally invasive HPB Surgery)
• What’s new ?

Following this course, the participant should be able to recognize the epidemiology and classify commonly presenting infectious diseases; identify the clinical manifestations, pathogenesis and methods of diagnosing the presenting diseases; and apply the current recommendations of pharmacologic management, referral or follow-up and prevention. This activity is expected to result in increased confidence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include: FM, IM, EM and Pediatrics, this course was designed to cover the spectrum of Infectious Diseases essential to all practicing physicians.

New for the 2010 Program:

• Three Postgraduate Courses, “Protocols in the ICU: Pro/Con Debates,” “Disaster Management,” and “Bridging the Gap between ICU and Rehab,” will be held onWednesday and Thursday afternoons. There will be NO charge for the course or the syllabus; please indicate your preferred session topic when you register.
• New this year, the two Firefighter Courses will be offered onWednesday and Thursday morning: “Chemical Retardants” and “Burn Injury Prevention.”
• Friday afternoon sessions will include: “Medical Records: A Visionary’s Perspective on Future Technologies” presented by the MAC; “The Burn Survivor’s Perspective” presented by the Aftercare Reintegration Committee (ARC) and “Stem Cell Research” presented by the Research Committee.

SACNA is honoured to invite you to our 12th Biennial Conference. With our country hosting the Soccer World Cup, 2010 is set to be a momentous year in the history of South African sport. Johannesburg will be in prime condition with many of the roads resurfaced and hopefully the Gautrain will even be in operation. 2010 will also be an exciting year for the South African neuropsychological community as the 12th biennial conference is set to be a bumper event not to be missed.

SACNA conferences are well known among South African psychologists for their high standard of speakers and organisation. The 2010 conference will be no exception as we are privileged to host two exceptional international keynote presenters, as well as a number of local invited speakers. The organising committee has been hard at work to ensure that this conference lives up to the usual standard.

This is an ideal forum for researchers from a variety of disciplines who are involved in research related to brain and behaviour to showcase their work. We therefore encourage you to submit your abstracts timeously. The conference is also an opportunity for psychologists to network with colleagues and exchange ideas. The conference will be an important learning opportunity for anyone with an interest in brain function. Students as well as those who are starting out in the neuropsychological field and/or related fields are especially welcome.

We look forward to meeting you at this exciting event.

Brian Mallinson
Chairman: Organising Committee

Following this program, participants should be able to:

• Integrate the updates to NCCN Guidelines for acute myeloid leukemia, breast cancer, cervical cancer, colon cancer, esophageal cancer, mesothelioma, multiple myeloma, non-small cell lung cancer, occult primary, and prostate cancer into professional practice
• Explain the connection between HPV and the risk of cancer
• Discuss new advances in the management of CNS metastases
• Describe the treatment strategies for treating young adults with cancer
• Discuss decision-making regarding chemotherapy in addition to other disease-directed and palliative therapies at end of life
• Explain the management of common adverse experiences related to cancer therapy
• Summarize the findings of the NCCN Task Forces: Gastrointestinal Stromal Tumors, Transfusion and Iron Overload in Myelodysplastic Syndromes, and Specialty Pharmacy in Oncology and Impact on Patient Care and Practice

New opportunities to learn and earn CME Credit From Adult Reconstruction: Hip and Sports Injuries to Maintenance of CertificationTM and Retirement Planning, Kappa Delta Award papers, and AAOS/Orthopaedic Research Society combined sessions; we’ve planned an exciting selection of educational opportunities. The traditional Tuesday offerings – such as the Practice Management Symposium and Coding Course for Orthopaedic Residents, the Practice Management Symposium for Orthopaedic Surgeons, and the playground build – will continue. you’ll be able to view the technical exhibits, the posters and scientific exhibits, visit the Resource Center Bookstore and Job Placement Center, and take in the Multimedia Education Center.

The conference topics include:

• Adult Recon/Hip
• Adult Recon/Knee
• Basic Research
• Foot & Ankle
• Hand & Wrist
• Pediatrics
• Practice/Non-Clinical
• Shoulder/Elbow
• Spine
• Sports Med/Arthroscopy
• Trauma
• Tumors/Metabolic Disease

The respiratory disorder market is highly competitive and brings in high revenues. The principal drivers are the increase in disease prevalence and the high economic cost of these diseases. With an increasing patient population and high-profile disorders, this market will continue to grow in the foreseeable future.

Happy to bring you its inaugural Respiratory Disorders Conference, which will feature keynote addresses, presentations, case studies and insights from outstanding speakers in this key area. This fundamental meeting will showcase the recent scientific developments and significant advances made in the COPD, Asthma, Pulmonary, Lung cancer treatments.

The International Society for Clinical Densitometry (ISCD) and the National Osteoporosis Foundation (NOF) have combined efforts to assist the clinican and technologist in receiving the most relevant information for clinical practice. This premier event combines the expertise of the two leading bone health organizations into one must-attend meeting.

Topics will include:

• Osteoporosis Diagnosis and Risk Assessment

• Clinical Considerations: Therapeutics

• Comprehensive Approach to Treatment: Education, Nutrition, Exercise

• Skeletal Health Across the Lifespan

• Hands On DXA Workshop

• Missed Opportunities in Osteoporosis Diagnosis and Treatment

• Use of Imaging in Clinical Diagnosis Lectures and Debate

• History of Bone Mass Measurement

• Using FRAX® in Practice: For Clinicians

You`ll find this Symposium chock-full of what you need to meet the care needs of patients with diverse pelvic floor disorders, and to enhance your own professional satisfaction. You`ll see that all the annual favorites are here, including:

• a variety of outstanding clinical workshop choices, where novice and expert can participate in in-depth learning together;
• general sessions highlighting up-to-the-minute, evidence-based care, and insights into what`s coming next;
• a variety of concurrent sessions providing opportunities to target your choices to explore the care needs of the specific populations you work with most closely; and
• special interest group meetings to allow you to network and learn from experts and peers.

After the success of 2009`s conference, SMi is proud to present their 6th Annual Imaging in Oncology.

Taking place in London, UK, this conference will focus on a wide range of imaging techniques in a wide range of settings - from the preclinical, to the clinical, to the future of oncological imaging.  You will hear presentations from the leading experts in their fields on the latest developments in MRI, PET, SPECT, IR, Raman Sepctroscopy and more.

The changes RECIST 1.1 has made - an assessment one year on.  How is MRI being used to guide biopsies?  Can less harmful techniques than PET be as effective in imaging a tumour?  Are nanoparticles the future for advanced cancer imaging?  Looking beyond tumour size - what techniques can help us understand the internal workings of a tumour?  How can we reduce the harmful effects of imaging?  How effective is proteomic profiling using mass spectrometry in diagnostics?

Attend this event to discover the power of imaging for developing new drugs, following the reaction to therapies and developing a personalised approach to the treatment of cancer.

WHY SHOULD YOU ATTEND?

• Gain a refresher/update on the technical aspects specific to the regulation of rDNA derived medicinal products
• Improve your knowledge of the differences between the regulation of rDNA products and conventional small molecule drugs
• Compare experiences with delegates from across Europe

* Please note – the seminar assumes a scientific background and a basic knowledge of drug regulatory affairs

WHO SHOULD ATTEND?

• Life scientists moving into biotech regulatory affairs
• Technical and scientific decision makers in biotech start up operations
• Those with a life science background in the financial sector involved in due diligence or regulatory portfolio
• Those from small molecule backgrounds transferring to biotech product regulatory affairs

Topics and Advances in Pulmonary and Critical Care Medicine: March 11—12, 2010

• General Session

• Critical Care

• Pulmonary Vascular Disease

This is a new great opportunity to welcome our friends from the Radiation Oncology Group of EORTC. Ten years ago, in spring of 2000, just after the change of the millennium, I had the pleasure of hosting you in my city. Now, I am keen to repeat this terrific experience. Today, economics is not in its best moments and funding is scarce for all, mainly for some medical specialties. This is especially harder for Radiation Oncology, as we have often faced such difficulties, and for many years, we have been working to demonstrate we are a key for cancer treatment. Despite this, we are preparing an excellent occasion to meet with all our ROG fellow members, as well as others that would like join us.

ROG is, arguably, the most active group in the history of EORTC, if based not just on scientific production but also in the personal sphere. Becoming a member of the ROG gave me the opportunity to learn a lot, including being active, in many clinical trials and the opportunity to share nice papers! Thanks to you all, one feels happy and at home with the ROG.

COPD: from evidence topractice will bring together leading experts in the field of respiratory medicine to discuss the current issues, latest developments and practical management of COPD.

It is anticipated that participants will benefit from:

• Comprehensive reviews of the fundamentals of COPD including an update on epidemiology, pathophysiology and co-morbid conditions
• An in depth focus on the management of stable disease including the importance of pharmacotherapy, pulmonary rehabilitation and home oxygen therapy
• A greater understanding of the management of acute exacerbations including the prevention of hospitalisation, the outcome of mechanical ventilation and the ethical issues surrounding resuscitation
• An overview of current models of care for COPD
• An insight into alternative therapeutic interventions including bronchoscopic and surgical interventions
• An opportunity to share and exchange ideas with leading practitioners in the field

• Recognize clinical presentation and treatment options of various urologic abnormalities
• Describe the various minimally invasive treatments for Urologic Diseases and their risk/benefits
• Apply Evidence Based Medicine (EBM) in urologic practice specifically incorporating AUA Guidelines into daily practice
• Understand the role of thermal therapies (e.g., Radiofrequency, Cryoablation, etc) in the treatment of urologic malignancies
• Describe the process involved in creating Guidelines and Best practice policies with review of recently released documents
• Identify basic laparoscopic applications and results in adult and pediatric patients
• Analyze data pertaining to various pharmacologic and surgical treatments for voiding dysfunction and urinary incontinence
• Recognize the latest diagnostic/treatment options for various renal anomalies
• Indicate current management options for urolithiasis (EBM)
• Understand new and modified treatments for erectile dysfunction, infertility, and penile malignancies
• Identify results of various laparoscopic and robotic approaches and techniques for benign and malignant urologic diseases
• Appraise research results and clinical series on management of prostate cancer and early diagnosis/screening in various patient populations
• Describe common pediatric urologic diseases and treatment updates
• Comprehend prognostic significance and treatments of various stages and grades of bladder cancer
• Identify techniques and results of various forms of urinary diversion
• Evaluate surgical techniques in video format to gain a greater understanding
• Identify socioeconomic factors affecting urologic training and clinical practice
• Design Wrap-up session to highlight current practice patterns.
• Understand the management issues pertaining to patients with Spinal cord injuries (SCI) and the unique urologic needs of such patients

The aim of this workshop, as with previous HLDA Workshops, is to provide an invaluable and ongoing service to the scientific community.

HLDA9 will study a panel of monoclonal antibodies against B cell-associated molecules. Only monoclonal antibodies against known cloned molecules will be included in the panel. Thus, no unknown antibody blind panels will be carried out. Some antibodies against known CD molecules expressed on B cells will also be included in this panel. MAbs will be provided by both researches and companies.

1. Determine the reactivity of the mAbs on normal B cells and B cell malignancies.
2. Defining new B cell subsets.
3. Determining the expression of the B-cell associated molecules on other hematopoietic and non-hematopoietic cells.
4. Identification and expression of intracellular molecules or epitopes of B cell associated molecules.
5. Study of phospho-epitopes and other intracellular signaling molecules such as adapter molecules
6. Determine the triggered activation/apoptosis induced by therapeutic mAbs, particularly chimeric/ humanised/human mAbs

Sections (updated)

The Workshop studies will be coordinated by four chairpersons, each responsible for a section.
For more details on the sections and how you can contribute, click on the links below (opens a new tab).

1. Normal B cell and B cell subsets (FACS analysis).
2. B-cell malignancies (FACS analysis): Chairman Dr. Valter Gattei (Italy).
3. Immunohistochemical analysis of normal and malignant cells.
4. Intracellular signaling molecules (FACS analysis and immunohistology).

This premium biennial College event embraces the theme “Interdisciplinary Dentistry for the New Decade: something for everyone”.

The Scientific Programme includes highly regarded international key note speakers, ably supported by Australasian lecturers. The Young Lecturer’s Award session will augment the Scientific Programme.

A comprehensive Trade Display will run concurrently with the Scientific Meeting.

The Opening Ceremony on the 11th March promises much interest. Apart from the formal induction of new Fellows and Members into the College, the opening address will be made by an eminent former military officer who works for NASA.

The 1st CODHy Latin America Congress will be devoted to evidence-based discussions amongst chairpersons, speakers and the audience, all of whom will examine and analyze the most relevant issues raised in 2009 and 2010 within the fields of Diabetes, Obesity and Hypertension.

We would like to invite you to attend the 10th Annual Spring Meeting of the European Society of Cardiology Council on Cardiovascular Nursing and Allied Professions  (CCNAP), organised in cooperation with the Working Group for Cardiovascular Nurses and Allied Professionals of the Swiss Society of Cardiology.

Join us in our mission to promote excellence in Cardiovascular Nursing and Allied Professions through practice, education and research.

This educational activity is designed for medical oncologists, infectious disease specialists, hematologists, hospitalists, and other physicians, physicians-in-training, and healthcare professionals interested and/or involved in the care of patients with febrile neutropenia.

Objectives

Upon completion of this activity, participants should be able to:

• Discuss and evaluate the clinical use of prophylactic versus empiric or preemptive therapy of fungal infections in febrile neutropenic patients
• Discuss the appropriate selection and practical utilization of replacement antibiotics for therapy of infections caused by resistant bacteria in febrile neutropenic patients
• Describe the role of native immunity on susceptibility and severity of infection in patients with febrile neutropenia
• Identify and assess management strategies for infections in patients undergoing stem cell transplant from alternative sources and donors
• Compare current and emerging therapies in the prevention and management of patients with febrile neutropenia

On behalf of the Scientific Committee, it is our pleasure to invite you to submit an abstract and to participate in the 1st International Abu Dhabi Diabetes Congress (ADDC), which will take place 12-14 March 2010.

The European Association for the Study of Diabetes (EASD) is responsible for the Scientific Programme. The congress will provide up to date information on all aspects of diabetes. Following the tradition of EASD the interaction and discussion with the speakers will be a major part of this meeting.

Abstract submission will open in July 2009, an official call for abstracts will follow in due course. The Scientific Committee will decide on the abstracts to be presented. This is based upon an anonymous review process.

Program Highlights

• Live Surgery!
• Robotic Radical Prostatectomy
• Partial Nephrectomy and Radical Cystectomy
• NOTES and Single Incision Laparoscopy
• Metabolic Stone Evaluations
• Prostate Cancer
• Bladder Cancer
• Optimizing Ureteroscopy and Percutaneous Nephrolithotomy

OBJECTIVES:

At the completion of the course the participants should be able to:

• Apply risk assessment methods to newly diagnosed prostate cancer patients and bladder cancer patients
• Assist patients diagnosed with localized prostate, bladder or kidney cancer in comparing and contrasting their options for treatment
• Identify the appropriate candidates for active surveillance as well as methods of patient follow-up and indications/contraindications for treatment
• Discuss advances in robotic radical prostatectomy and radiation therapy techniques
• Discuss advances in the treatment of urinary bladder and kidney cancer
• Evaluate and apply the available chemotherapy and biologic therapy regimens for patients with high-risk prostate, bladder and kidney cancer
• Demonstrate knowledge of the appropriate metabolic evaluation of patients with urinary stone disease
• Describe the indications and technical advances in the endoscopic management of urinary stone disease

7-Night Cruise Conference from Ft. Lauderdale, Florida

Course Objective: To review the diagnosis and management of dermatological conditions commonly encountered by the Primary Care Physician.
To improve the non-dermatologists ability to diagnose, treat and manage the patient with skin related conditions.
Preliminary Topics for Activity

Skin Disease and Bio-terrorism
Common Skin Infections
Benign or Malignant - Recognizing Skin Lesions
Practical Office Skin Pearls for Non-Dermatologists
Acne and Rosacea for the Primary Care Physician
Psychodermatology

*A Psychiatry Review Course Exclusive*: What better way to spend a week in March than enjoying a Disney CME cruise? A cruise aboard a Disney ship is a unique experience unlike any other cruise. Naturally, Disney is great for children and families, but you might be surprised to learn that a Disney cruise rivals or surpasses the elegance of the more `traditional` top-rated cruiselines. Adults and couples, and not only children, routinely rave about their Disney cruise experience!

The nautically themed Disney Magic cruiseship evokes the era of grand cruiseliners, and the experience on board is both fun and elegant. A great deal of attention has been paid by Disney towards ensuring that all guests can enjoy the experience they seek. Children can play in their own space under the supervision of trained counsellors, and have access to unmatched Disney childrens` programmes; families can spend time together in family areas; and adults can spend time alone in adult designated areas. The activities and spaces aboard the ship are designed to facilitate all these needs, with areas dedicated not only for children, but also adult-only spaces, including entertainment venues and pools.

There will be approximately 14.5 hours of CME group sessions during this conference, featuring a mixture of general and specialized topics in psychiatry, plus an optional additional 8 hours in our CME To Go program.

By exhibiting at ACC.10, you will have access to the most influential buyers of your products and the leading subscribers to your services. This is your opportunity to have one-on-one conversations with the professionals who will prescribe your medications, purchase your equipment, and utilize your services.

We will be adding and updating content on this Web site, so please check back frequently to learn more about what is being planned for the Exposition and the 59th Annual Scientific Session of the American College of Cardiology.

A vital part of your ACC education can be found on the ACC.10 Exposition floor. Gain an understanding of the latest advances in pharmaceuticals, imaging, devices and the services that you need to help you provide high quality patient care. The ACC.10 Expo will feature innovative cardiovascular products and services being shown by more than 225 exhibiting companies.

All physicians have that "challenging patient" in their practice
- but what does one do? How do we manage their care?

This conference will have an emphasis on practical tips and take home `pearls` with a focus on managment of the challenging
patient with Mental Health | Disabilities | Addictions | Medical Legal issues.

Designed for ALL physicians - FP`s and Specialists

There will also be a module on Practice Management for physicians and office staff provided by Practice Solutions.

The 10th Annual Rachmiel Levine Symposium, entitled Advances in Diabetes Biology, Immunology and Cell Therapy, will be held March 14-17, 2010 at Caesars Palace in Las Vegas, Nevada.  The program will cover topics in islet biology, including beta cell regeneration, and in islet immunology, including new advances in understanding autoimmunity, role of inflammation in the genesis of disease and current and future strategies for immune modulation as treatment modalities.  In addition, the meeting will cover topics linking pathophysiology of type 1 and type 2 diabetes and new insight into metabolic effects of bariatric surgery, metabolic changes in pregnancy, and closed loop system development.  

The meeting will also highlight the results of recent diabetes clinical trials and conduct technical workshops in islet biology and include a poster session, oral session, debate sessions, and a keynote dinner lectureship.

The importance of developing effective pharmacovigilance systems has been fuelled by an increased focus on drug safety and the ever-changing regulatory environment. SMi’s inaugural Pharmacovigilance conference will explore key issues such as inspections, risk management, the use of Independent Data Monitoring Committees and establishing relationships with regulatory bodies. Attend and gain insights that will enhance your management skills and facilitate a more successful drug development strategy.

• eHealth for Sustainable Healthcare Delivery
• eHealth Addressing Global Challenges through Local Actions
• eHealth works: Here is the Evidence
• eHealth Market: Past and Prospects
• eHealth User Platform

However, we are confident that this educational program will also appeal to any primary-care physicians looking to enhance their emergency medicine skill sets.

Following this course, the participant should be able to develop an approach to the patient with metabolic disorders to arrive at a cost-effective diagnosis; apply a treatment plan that considers lifestyles, medications and specialty referral or monitoring needs; identify patients likely to develop complications and determine the long-term needs as well as resource management. This activity is expected to result in increased confidence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Since Internal Medicine takes a lead role in medicine in general, this course was designed for all practitioners at the level of a practicing physician to provide a review and up-date in their medical knowledge and abilities to diagnose, treat and improve patient care.

CNS is one of the largest and fastest growing therapeutic areas of the
pharmaceutical market. The ageing of the baby-boom generation combined
with new and emerging treatments for neurodegenerative disorders, including multiple sclerosis, Alzheimer’s disease and Parkinson’s disease, will lead to further expansion of the neurodegenerative therapies market.

CNS Clinical Trials conference you will examine the strategies offering
the greatest potential for success in CNS drug development, and understand the specifi c
challenges currently faced by developers in this market. In order to enhance productivity
in this fi eld, there has been an increased awareness of the need to align clinical and
preclinical research to facilitate rapid development of new CNS drug therapies. Medical
imaging is increasingly being used as a surrogate endpoint or biomarker of drug effi cacy
in all phases of CNS trials, enabling CNS developers to make more timely decisions.

Since 1994 PPTA’s Congresses have provided valuable insights into the issues affecting the plasma protein industry.

IPPC has been the primary international congress for all stakeholders of plasma protein therapies. Building on the experience and success of the past but with a clear eye to the future, the IPPC 2010 offers delegates a unique, two-day programme with speakers of the highest calibre, representing institutions and organizations that provide leadership and direction in several important areas.

Sessions will feature topics such as clinical developments, patient access, self-sufficiency, regulatory considerations, plasma collection, health policy and much more. There will be ample time for discussion and questions after the presentations and during the cocktail buffet reception on 16 March which will complement the full and diverse programme.

The interests of patients and physicians are everyone’s number one priority, be they politicians, regulators, scientists, healthcare funding organizations and for those working in the industry.  Our intention is to create a congress for all.

• Find the right fit supply chain and logistics model for Asia – Learn from the Pharmaceutical and Biotech Power Panel where leaders from various countries sit together and share their solutions
   
• Re-evaluate your client-LSP relationship from a fresh point of view – Learn to form a win-win relationship and leverage on their strengths to realize long-term goals.
   
• Case studies from leading manufacturers – Learn from their mistakes and successes and get valuable tips for the development of your own company’s logistics and supply chain strategy
   
• 2 whole days of unparalleled networking – Meet senior level executives from Asia’s leading pharmaceutical and biotech manufacturers. Share ideas, learn from others and build valuable and lasting partnerships
   
• Focused event – This is guaranteed to be the most relevant and cost-effective conference you will attend all year
  

It is the largest gathering of a diverse, multidisciplinary community of professionals from the fields of aging, healthcare and education. Join us to find the answers, the experts, the research, the best practices, and the most comprehensive educational offerings available to professionals. The conference provides attendees with the opportunity to network with new and old friends, gain insight from voices from the front line and find new grassroots and national partners for advocacy.

Attendees come from around the country and abroad to find the answers, the experts, the research, the best practices, and the most comprehensive educational offerings available to professionals. It is the place to be if you want to learn about what’s new, what works, and how you can make it work to respond to the ever-growing demands of serving an aging population. The conference provides attendees with the opportunity to network with new and old friends, gain insight from voices from the front line and find new grassroots and national partners for advocacy.

The recent ECDC/EMEA Technical Report - The bacterial challenge: time to react has highlighted the urgent need for development of new antimicrobial drugs.

Pharmacovigilance is becoming ever more critical for pharmaceutical companies as the public and legislative pressure to ensure drug safety increases every day. Effective implementation of pharmacovigilance can aid drug development, benefit rational communication and sound public understanding, taking emerging regulatory policies worldwide into account. The challenge to manage adverse events in an optimal and efficient way and, at the same time, adhere to regulatory requirements will demand a great emphasis on pharmacovigilance in the near future.

The 14th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myelomas provides a unique opportunity for physicians to learn from and to interact with international leaders in the field of hematologic malignancies in order to increase knowledge, apply new data to practice, and ultimately improve patient outcomes. This international CME-designated congress offers physicians the opportunity to learn about the latest developments in the treatment of hematologic malignancies, including findings presented at recent major oncology conferences, updates on the landscape for new drug indications and new agents, and ongoing clinical trials expected to impact practice in the near future. The instructional format of the congress is varied and includes didactic lectures, panel discussions, debates, and case-based presentations in order to accommodate the different learning styles of the participants. The congress is highly interactive, providing multiple opportunities for faculty-participant interaction. The multiple instructional formats used will enhance the learning experience and foster the integration of evidence-based patient care into everyday community practice.

Bipolar disorder is one of the most active and rapidly evolving areas of psychiatry, and this meeting will provide an opportunity to hear cutting edge findings, presented by a select panel of internationally recognized experts in the area. The educational program will comprise plenary lectures, symposia, workshops, oral communications and poster sessions, and a forum for involving patient advocacy and support groups.

Congress official language is Turkish.(Translated by Google)

Dear Friends & Colleagues

The congress will present the most recent advances in the field of cardiovascular disease therapy.